| 注册
首页|期刊导航|临床肝胆病杂志|再谈聚乙二醇干扰素α在慢性乙型肝炎个体化治疗中的应用

再谈聚乙二醇干扰素α在慢性乙型肝炎个体化治疗中的应用

万谟彬

临床肝胆病杂志2018,Vol.34Issue(5):930-933,4.
临床肝胆病杂志2018,Vol.34Issue(5):930-933,4.DOI:10.3969/j.issn.1001-5256.2018.05.004

再谈聚乙二醇干扰素α在慢性乙型肝炎个体化治疗中的应用

Individualized treatment with pegylated interferon-α for chronic hepatitis B

万谟彬1

作者信息

  • 1. 上海长海医院感染科,上海200433
  • 折叠

摘要

Abstract

Antiviral therapy is the basic treatment of chronic hepatitis B,and pegylated interferon-α is one of the first-line treatment drugs.At present,several consensuses have been reached on individualized treatment with pegylated interferon-o,which is playing an important role in clinical practice.New clinical demands appear along with the clinical application of pegylated interferon-α.With reference to relevant literature and personal clinical experience,this article elaborates on some knowledge of individualized treatment with pegylated interferon-α for chronic hepatitis B.

关键词

肝炎,乙型,慢性/干扰素α/治疗

Key words

hepatitis B, chronic/interferon-alpha/therapy

分类

医药卫生

引用本文复制引用

万谟彬..再谈聚乙二醇干扰素α在慢性乙型肝炎个体化治疗中的应用[J].临床肝胆病杂志,2018,34(5):930-933,4.

临床肝胆病杂志

OA北大核心CSTPCD

1001-5256

访问量0
|
下载量0
段落导航相关论文